AARD - Aardvark Therapeutics Inc.
6.11
0.390 6.383%
Share volume: 181,776
Last Updated: 05-12-2026
Pharmaceutical Products/Pharmaceutical Preparations:
0.10%
PREVIOUS CLOSE
CHG
CHG%
$5.72
0.39
0.07%
Summary score
46%
Profitability
35%
Dept financing
28%
Liquidity
50%
Performance
60%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2022 - 2026
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-14.68%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
8.24%
Debt ratio change over timeo
0%
Current Ratio
14.14%
Quick Ratio
0%
Cash Position Ratio
4.48%
Short-term ratios 2025 - 2026
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-17.35%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
9.64%
Debt ratio change over timeo
0%
Current Ratio
10.24%
Quick Ratio
0%
Cash Position Ratio
4.5%
Last quarter ratios 2026
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-22.8%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
11.77%
Debt ratio change over time
0%
Current Ratio
8.06%
Quick Ratio
0%
Cash Position Ratio
5.38%
Performance ratios (change over 4 years) 2022 - 2026
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AARD | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 10.6% | 11.11% | 0% |
| Return on assets | -14.68% | 4.87% | 3.15% | 0% |
| Return on sales | 0% | 31.64% | 25.21% | 0% |
| Return on invested capital | 0% | 7.36% | 11.75% | 0% |
| Profitability | 0% | 90% | 86% | 0% |
| Total debt ratio | 8.24% | 79.95% | 59.47% | 0% |
| Debt ratio change over time | 0% | -25.01% | -101.26% | 0% |
| Dept financing | 28% | 25% | 19% | 0% |
| Current Ratio | 10.24% | 1.47% | 1.03% | 0% |
| Quick Ratio | 0% | 1.13% | 0.77% | 0% |
| Cash Position Ratio | 4.5% | 0.17% | 0.36% | 0% |
| Liquididy | 50% | 28% | 28% | 0% |
| Short-term ratios | AARD | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -17.35% | 6.99% | 3.19% | 0% |
| Return on sales | 0% | 43.61% | 26.42% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 27% | 0% |
| Total debt ratio | 9.64% | 77.72% | 59.24% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 28% | 25% | 19% | 0% |
| Current Ratio | 10.24% | 1.47% | 1.03% | 0% |
| Quick Ratio | 0% | 1.13% | 0.77% | 0% |
| Cash Position Ratio | 4.5% | 0.17% | 0.36% | 0% |
| Liquididy | 50% | 30% | 22% | 0% |